The Evolution of Chemoimmunotherapy in Advanced NSCLC
Closing their discussion, the panel shares their final thoughts on recent updates in advanced NSCLC and looks to the future of treatment.
Source: onclive.com
Page 19 - Molecular Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Molecular Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Molecular Testing Today - Breaking & Trending Today
Selecting Therapy for Advanced NSCLC Based on PDL1 and NGS Testing
Shared insight on the value that molecular testing and PDL1 testing, respectively, have on determining optimal therapy for patients with advanced non–small cell lung cancer.
Source: onclive.com
New Research Results Spotlight Rare Molecular Subtypes in NSCLC
Although molecularly targeted therapies have transformed the treatment paradigm for NSCLC, the kaleidoscope of genomic alterations that affects subsets of patients is straining the limits of current diagnostic and clinical discovery approaches.
Source: onclive.com
CareDx Reports First Quarter 2023 Results
CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients... | May 10, 2023
Source: marketscreener.com
Audience Q&A: Best Practices in Managing HER2-Amplified CRC
Fielding questions from the audience, expert oncologists discuss clinical trials, molecular testing, and early-stage disease in the context of HER2-amplified colorectal cancer.
Source: onclive.com